Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Liangshu Feng, [email protected] These authors have contributed equally to this work and share first authorship Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
While nausea is common and expected, it does not necessarily indicate the medication is working better
The Journey Through Clinical Trials A medication does not receive FDA approval overnight
However, it was not as effective as Sitagliptin, the drug inhibitor of DPP-IV, which produced a 27 % reduction in plasma glucose relative to the control
Additionally, the medication led to decreases in various factors associated with an increased risk of heart and metabolic diseases, including blood pressure, visceral adiposity, and circulating triglycerides
US$ 21.48
US$ 27.16
US$ 24.13
US$ 25.41
US$ 27.97
US$ 23.03
US$ 22.37
US$ 20.62
